Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Neurology CRO

Vial welcomes Dr. Rajesh Pahwa to their Neurology CRO.

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board

San Francisco, CA. November 16, 2022 — Vial welcomes Rajesh Pahwa, MBBS, MD, as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Pahwa is Chief of the Parkinson’s and Movement Disorder Division and a professor of neurology at the University of Kansas Medical Center, which has been designated as one of 33 Centers …

Vial Welcomes Dr. Rajesh Pahwa, Chief of the Parkinson’s and Movement Disorder Division at the University of Kansas Medical Center, to its Central Nervous System Scientific Advisory Board Read More »

Dr. Robert Hauser becomes scientific advisor to Vial's Neurology CRO.

Robert A. Hauser, MD, MBA, of the Parkinson’s Disease and Movement Disorders Center, University of South Florida, joins Vial’s Neurology CRO Scientific Advisory Board.

San Francisco, CA. November 7, 2022 — Vial welcomes Robert A. Hauser, MD, MBA, as a new Central Nervous System (CNS) advisory board member to their Neurology CRO. Dr. Hauser is the Director of the Parkinson’s Disease and Movement Disorder Center and a Professor of Neurology, at the University of South Florida. Vial is a tech-enabled CRO providing next-generation clinical …

Robert A. Hauser, MD, MBA, of the Parkinson’s Disease and Movement Disorders Center, University of South Florida, joins Vial’s Neurology CRO Scientific Advisory Board. Read More »